BT
Biotest AG
BTTAY · OTC
$24.21 -0.10% (-$0.02)
Piotroski F-Score Moderate
4/9Valuation
-
N/A P/FCF N/A
P/E N/A
EV/FFO N/A
Growth
-
N/A FCF growth N/A
EPS growth N/A
Book val. growth N/A
Profitability
-
N/A Op. margin N/A
Gross margin N/A
FCF margin N/A
Quality
-
N/A ROA N/A
ROIC N/A
Asset turnover N/A
Debt
-
N/A Debt/Assets N/A
Debt/Equity N/A
Net debt/EBITDA N/A
Stability
0 /100
Unstable Beta 0.00x
Profitable years N/A
Rev. volatility N/A
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na BTTAY
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Jorg Schuttrumpf
Employees
2,495
Headquarters
Dreieich